♥

GUJARAT THEMIS BIOSYN LTD

ISIN : INE942C01029
BSE : 506879
Face Value : 5
Industry : Pharmaceuticals & Drugs

EPS : 8.14
EPS (TTM) : 6.77
Price to Earning (P/E) : 30.90
Book Value : 27.72
Price to Bookvalue (P/B) : 9.07
Dividend Yield : 0 %
Return on Equity (ROE) : 33.76 %
Return on Capital Employed (ROCE) : 45.40 %

GUJARAT THEMIS share price (02-Apr-2026)
Bombay Stock Exchange BSE
Open / Close	248.9 - 251.5 1 %
Low / High	236.1 - 253.5 7.4 %
Trade Volume	9,275
52 Week Low / High	225.75 - 479.45 112.4 %

YOU MAY ALSO LIKE

CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
Share Market basics for beginners
Share Market jargons in simple terms
Stock market course tutorial
Stock Market Investment Course explained in simple words.
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR GUJARAT THEMIS BIOSYN LTD

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	449.44	476.91	281.65	281.73	495.88	396.54	388.59	420.11	388.27	347.16
Total Income	463.67	490.87	299.71	295.71	506.63	406.54	398.63	430.3	393.52	350.35
Total Expenditure	221.65	232.89	160.54	132.46	260.82	228.34	211.14	210.81	202.77	193.25
Other Income	14.23	13.96	18.06	13.99	10.75	10.01	10.04	10.18	5.24	3.19
Operating Profit	242.02	257.98	139.17	163.25	245.81	178.2	187.49	219.49	190.75	157.1
Interest	0.62	0.42	0.71	0.25	0.25	0.51	0.79	0.75	0.66	0.82
PBDT	241.4	257.56	138.46	163	245.56	177.69	186.7	218.74	190.09	156.28
Depreciation	5.7	5.79	6.58	7.69	7.49	8.84	9.78	9.25	11.48	14.36
Profit Before Tax	235.7	251.77	131.88	155.31	238.07	168.85	176.92	209.49	178.61	141.92
Tax	57.99	64.78	33.81	38.39	60.86	43.43	46.8	50.63	46.24	36.25
Profit After Tax	177.71	186.99	98.07	116.92	177.21	125.42	130.12	158.86	132.37	105.67
Net Profit	177.71	186.99	98.07	116.92	177.21	125.42	130.12	158.86	132.37	105.67
Equity Capital	72.64	72.64	72.64	72.64	72.64	72.64	72.64	72.64	72.64	108.97
Face Value (IN RS)	5	5	5	5	5	5	1	1	1	1
Calculated EPS	12.23	12.87	6.75	8.05	12.2	8.63	1.79	2.19	1.82	0.97
Diluted Eps After Extraordinary Items	12.23	12.87	6.75	8.05	12.2	8.63	1.79	2.19	1.82	0.97
Diluted Eps Before Extraordinary Items	12.23	12.87	6.75	8.05	12.2	8.63	1.79	2.19	1.82	0.97

STANDALONE QUARTERLY RESULT FOR GUJARAT THEMIS BIOSYN LTD

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	449.44	476.91	281.65	281.73	495.88	396.54	388.59	420.11	388.27	347.16
Total Income	463.67	490.87	299.71	295.71	506.63	406.54	398.63	430.3	393.52	350.35
Total Expenditure	221.65	232.89	160.54	132.46	260.82	228.34	211.14	210.81	202.77	193.25
Other Income	14.23	13.96	18.06	13.99	10.75	10.01	10.04	10.18	5.24	3.19
Operating Profit	242.02	257.98	139.17	163.25	245.81	178.2	187.49	219.49	190.75	157.1
Interest	0.62	0.42	0.71	0.25	0.25	0.51	0.79	0.75	0.66	0.82
PBDT	241.4	257.56	138.46	163	245.56	177.69	186.7	218.74	190.09	156.28
Depreciation	5.7	5.79	6.58	7.69	7.49	8.84	9.78	9.25	11.48	14.36
Profit Before Tax	235.7	251.77	131.88	155.31	238.07	168.85	176.92	209.49	178.61	141.92
Tax	57.99	64.78	33.81	38.39	60.86	43.43	46.8	50.63	46.24	36.25
Profit After Tax	177.71	186.99	98.07	116.92	177.21	125.42	130.12	158.86	132.37	105.67
Net Profit	177.71	186.99	98.07	116.92	177.21	125.42	130.12	158.86	132.37	105.67
Equity Capital	72.64	72.64	72.64	72.64	72.64	72.64	72.64	72.64	72.64	108.97
Face Value (IN RS)	5	5	5	5	5	5	1	1	1	1
Calculated EPS	12.23	12.87	6.75	8.05	12.2	8.63	1.79	2.19	1.82	0.97
Diluted Eps After Extraordinary Items	12.23	12.87	6.75	8.05	12.2	8.63	1.79	2.19	1.82	0.97
Diluted Eps Before Extraordinary Items	12.23	12.87	6.75	8.05	12.2	8.63	1.79	2.19	1.82	0.97

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR GUJARAT THEMIS BIOSYN LTD

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	1148.54	1489.73	1698.22
Total Income	1189.04	1549.97	1741.88
Total Expenditure	568.09	747.55	910.88
Other Income	40.5	60.24	43.66
Operating Profit	620.95	802.42	831
Interest	8.28	2.01	2.29
PBDT	612.67	800.41	828.71
Depreciation	22.33	25.76	35.36
Profit Before Tax	590.34	774.65	793.35
Tax	154.1	194.96	201.71
Profit After Tax	436.24	579.69	591.64
Net Profit	436.24	579.69	591.64
Equity Capital	72.64	72.64	72.64
Face Value (IN RS)	5	5	1
Reserves	960.57	1418.82	1941.12
Calculated EPS	30.03	39.9	8.14
Diluted Eps After Extraordinary Items	30.03	39.9	8.14
Diluted Eps Before Extraordinary Items	30.03	39.9	8.14

STANDALONE ANNUAL RESULT FOR GUJARAT THEMIS BIOSYN LTD

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	1148.54	1489.73	1698.22
Total Income	1189.04	1549.97	1741.88
Total Expenditure	568.09	747.55	910.88
Other Income	40.5	60.24	43.66
Operating Profit	620.95	802.42	831
Interest	8.28	2.01	2.29
PBDT	612.67	800.41	828.71
Depreciation	22.33	25.76	35.36
Profit Before Tax	590.34	774.65	793.35
Tax	154.1	194.96	201.71
Profit After Tax	436.24	579.69	591.64
Net Profit	436.24	579.69	591.64
Equity Capital	72.64	72.64	72.64
Face Value (IN RS)	5	5	1
Reserves	960.57	1418.82	1941.12
Calculated EPS	30.03	39.9	8.14
Diluted Eps After Extraordinary Items	30.03	39.9	8.14
Diluted Eps Before Extraordinary Items	30.03	39.9	8.14

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR GUJARAT THEMIS BIOSYN LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	90.56 Cr	114.85 Cr	148.97 Cr	169.82 Cr
Sales	90.42 Cr	114.19 Cr	148.13 Cr	169.81 Cr
Net Sales	90.56 Cr	114.85 Cr	148.97 Cr	169.82 Cr
Increase/Decrease in Stock	-38.11 Lk	-5.13 Cr	-3.24 Cr	11.01 Cr
Raw Material Consumed	15.51 Cr	21.23 Cr	29.01 Cr	24.71 Cr
Opening Raw Materials	1.58 Cr	1.12 Cr	1.43 Cr	96.94 Lk
Purchases Raw Materials	15.09 Cr	21.54 Cr	28.56 Cr	24.8 Cr
Closing Raw Materials	1.16 Cr	1.43 Cr	96.94 Lk	1.06 Cr
Power & Fuel Cost	16.57 Cr	21.73 Cr	26.41 Cr	26.53 Cr
Electricity & Power	12.6 Cr	14.9 Cr	17.88 Cr	19.82 Cr
Oil, Fuel & Natural gas	3.29 Cr	5.95 Cr	7.48 Cr	5.45 Cr
Employee Cost	7.11 Cr	7.08 Cr	7.75 Cr	10.21 Cr
Salaries, Wages & Bonus	6.7 Cr	6.64 Cr	7.07 Cr	8.96 Cr
Contributions to EPF & Pension Funds	23.48 Lk	23.41 Lk	24.99 Lk	39.57 Lk
Workmen and Staff Welfare Expenses	12.76 Lk	15.02 Lk	34.66 Lk	73.47 Lk
Other Manufacturing Expenses	9.35 Cr	9 Cr	10.62 Cr	13.64 Cr
Processing Charges	37.7 Lk	37.99 Lk	41.75 Lk	55.31 Lk
Repairs and Maintenance	1.45 Cr	1.51 Cr	1.19 Cr	1.86 Cr
Packing Material Consumed	16.12 Lk	30.91 Lk	37.93 Lk	32.5 Lk
General and Administration Expenses	1.16 Cr	1.32 Cr	2.53 Cr	2.76 Cr
Rent , Rates & Taxes	21.19 Lk	23.79 Lk	35.36 Lk	42.65 Lk
Insurance	40.3 Lk	41.4 Lk	47.35 Lk	49.6 Lk
Printing and stationery	5.57 Lk	7.35 Lk	11.05 Lk	13.83 Lk
Professional and legal fees	19.02 Lk	33.99 Lk	1.1 Cr	85.51 Lk
Traveling and conveyance	93,000	4 Lk	13.98 Lk	50.52 Lk
Selling and Distribution Expenses	38.22 Lk	30.92 Lk	1.04 Cr	1.6 Cr
Sales Commissions & Incentives	6.5 Lk	0	0	1.2 Cr
Freight and Forwarding	31.72 Lk	30.92 Lk	1.04 Cr	40.04 Lk
Miscellaneous Expenses	53.2 Lk	1.26 Cr	64.39 Lk	60.98 Lk
Provision for doubtful debts	0	23.94 Lk	0	0
Loss on foreign exchange fluctuations	15,000	0	0	0
Total Expenditure	50.23 Cr	56.81 Cr	74.76 Cr	91.09 Cr
Other Income	3.27 Cr	4.05 Cr	6.02 Cr	4.37 Cr
Interest Received	2.15 Cr	3.26 Cr	5.13 Cr	4.03 Cr
Profit on sale of Fixed Assets	1.22 Lk	0	0	0
Provision Written Back	1.1 Cr	75.34 Lk	87.11 Lk	90,000
Foreign Exchange Gains	0	94,000	0	0
Operating Profit	43.6 Cr	62.1 Cr	80.24 Cr	83.1 Cr
Interest	98.14 Lk	82.78 Lk	20.07 Lk	22.92 Lk
Interest on Term Loan	44.07 Lk	48.78 Lk	0	0
Bank Charges etc	19.19 Lk	9.5 Lk	8.67 Lk	8.67 Lk
PBDT	42.61 Cr	61.27 Cr	80.04 Cr	82.87 Cr
Depreciation	1.73 Cr	2.23 Cr	2.58 Cr	3.54 Cr
Profit Before Taxation & Exceptional Items	40.88 Cr	59.03 Cr	77.46 Cr	79.33 Cr
Profit Before Tax	40.88 Cr	59.03 Cr	77.46 Cr	79.33 Cr
Provision for Tax	10.7 Cr	15.41 Cr	19.5 Cr	20.17 Cr
Current Income Tax	10.35 Cr	15.01 Cr	19.24 Cr	19.51 Cr
Deferred Tax	12.61 Lk	7.24 Lk	25.54 Lk	37.51 Lk
Profit After Tax	30.18 Cr	43.62 Cr	57.97 Cr	59.16 Cr
Consolidated Net Profit	30.18 Cr	43.62 Cr	57.97 Cr	59.16 Cr
Profit Balance B/F	32.61 Cr	60.36 Cr	93.74 Cr	139.56 Cr
Appropriations	62.79 Cr	103.99 Cr	151.7 Cr	198.72 Cr
Other Appropriation	2.43 Cr	8 Lk	5.75 Cr	1.48 Cr
Equity Dividend %	0	220	108	100
Earnings Per Share	20.77	30.03	39.9	8.14
Adjusted EPS	20.77	30.03	39.9	8.14

STANDALONE PROFIT / LOSS FOR GUJARAT THEMIS BIOSYN LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	90.56 Cr	114.85 Cr	148.97 Cr	169.82 Cr
Sales	90.42 Cr	114.19 Cr	148.13 Cr	169.81 Cr
Net Sales	90.56 Cr	114.85 Cr	148.97 Cr	169.82 Cr
Increase/Decrease in Stock	-38.11 Lk	-5.13 Cr	-3.24 Cr	11.01 Cr
Raw Material Consumed	15.51 Cr	21.23 Cr	29.01 Cr	24.71 Cr
Opening Raw Materials	1.58 Cr	1.12 Cr	1.43 Cr	96.94 Lk
Purchases Raw Materials	15.09 Cr	21.54 Cr	28.56 Cr	24.8 Cr
Closing Raw Materials	1.16 Cr	1.43 Cr	96.94 Lk	1.06 Cr
Power & Fuel Cost	16.57 Cr	21.73 Cr	26.41 Cr	26.53 Cr
Electricity & Power	12.6 Cr	14.9 Cr	17.88 Cr	19.82 Cr
Oil, Fuel & Natural gas	3.29 Cr	5.95 Cr	7.48 Cr	5.45 Cr
Employee Cost	7.11 Cr	7.08 Cr	7.75 Cr	10.21 Cr
Salaries, Wages & Bonus	6.7 Cr	6.64 Cr	7.07 Cr	8.96 Cr
Contributions to EPF & Pension Funds	23.48 Lk	23.41 Lk	24.99 Lk	39.57 Lk
Workmen and Staff Welfare Expenses	12.76 Lk	15.02 Lk	34.66 Lk	73.47 Lk
Other Manufacturing Expenses	9.35 Cr	9 Cr	10.62 Cr	13.64 Cr
Processing Charges	37.7 Lk	37.99 Lk	41.75 Lk	55.31 Lk
Repairs and Maintenance	1.45 Cr	1.51 Cr	1.19 Cr	1.86 Cr
Packing Material Consumed	16.12 Lk	30.91 Lk	37.93 Lk	32.5 Lk
General and Administration Expenses	1.16 Cr	1.32 Cr	2.53 Cr	2.76 Cr
Rent , Rates & Taxes	21.19 Lk	23.79 Lk	35.36 Lk	42.65 Lk
Insurance	40.3 Lk	41.4 Lk	47.35 Lk	49.6 Lk
Printing and stationery	5.57 Lk	7.35 Lk	11.05 Lk	13.83 Lk
Professional and legal fees	19.02 Lk	33.99 Lk	1.1 Cr	85.51 Lk
Traveling and conveyance	93,000	4 Lk	13.98 Lk	50.52 Lk
Selling and Distribution Expenses	38.22 Lk	30.92 Lk	1.04 Cr	1.6 Cr
Sales Commissions & Incentives	6.5 Lk	0	0	1.2 Cr
Freight and Forwarding	31.72 Lk	30.92 Lk	1.04 Cr	40.04 Lk
Miscellaneous Expenses	53.2 Lk	1.26 Cr	64.39 Lk	60.98 Lk
Provision for doubtful debts	0	23.94 Lk	0	0
Loss on foreign exchange fluctuations	15,000	0	0	0
Total Expenditure	50.23 Cr	56.81 Cr	74.76 Cr	91.09 Cr
Other Income	3.27 Cr	4.05 Cr	6.02 Cr	4.37 Cr
Interest Received	2.15 Cr	3.26 Cr	5.13 Cr	4.03 Cr
Profit on sale of Fixed Assets	1.22 Lk	0	0	0
Provision Written Back	1.1 Cr	75.34 Lk	87.11 Lk	90,000
Foreign Exchange Gains	0	94,000	0	0
Operating Profit	43.6 Cr	62.1 Cr	80.24 Cr	83.1 Cr
Interest	98.14 Lk	82.78 Lk	20.07 Lk	22.92 Lk
Interest on Term Loan	44.07 Lk	48.78 Lk	0	0
Bank Charges etc	19.19 Lk	9.5 Lk	8.67 Lk	8.67 Lk
PBDT	42.61 Cr	61.27 Cr	80.04 Cr	82.87 Cr
Depreciation	1.73 Cr	2.23 Cr	2.58 Cr	3.54 Cr
Profit Before Taxation & Exceptional Items	40.88 Cr	59.03 Cr	77.46 Cr	79.33 Cr
Profit Before Tax	40.88 Cr	59.03 Cr	77.46 Cr	79.33 Cr
Provision for Tax	10.7 Cr	15.41 Cr	19.5 Cr	20.17 Cr
Current Income Tax	10.35 Cr	15.01 Cr	19.24 Cr	19.51 Cr
Deferred Tax	12.61 Lk	7.24 Lk	25.54 Lk	37.51 Lk
Profit After Tax	30.18 Cr	43.62 Cr	57.97 Cr	59.16 Cr
Consolidated Net Profit	30.18 Cr	43.62 Cr	57.97 Cr	59.16 Cr
Profit Balance B/F	32.61 Cr	60.36 Cr	93.74 Cr	139.56 Cr
Appropriations	62.79 Cr	103.99 Cr	151.7 Cr	198.72 Cr
Other Appropriation	2.43 Cr	8 Lk	5.75 Cr	1.48 Cr
Equity Dividend %	0	220	108	100
Earnings Per Share	20.77	30.03	39.9	8.14
Adjusted EPS	20.77	30.03	39.9	8.14

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR GUJARAT THEMIS BIOSYN LTD

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	40.88 Cr	59.03 Cr	77.46 Cr	79.33 Cr
Adjustment	-23.99 Lk	15.42 Lk	-2.43 Cr	46.44 Lk
Changes In working Capital	-19.98 Cr	-4.36 Cr	-15.11 Cr	4.19 Cr
Cash Flow after changes in Working Capital	20.66 Cr	54.83 Cr	59.92 Cr	83.99 Cr
Cash Flow from Operating Activities	10.53 Cr	40.31 Cr	39.5 Cr	64.21 Cr
Cash Flow from Investing Activities	-2.25 Cr	-29.83 Cr	-20.41 Cr	-55.21 Cr
Cash Flow from Financing Activitie	-5.16 Cr	-14 Cr	-13.3 Cr	-8.59 Cr
Net Cash Inflow / Outflow	3.12 Cr	-3.51 Cr	5.79 Cr	41.42 Lk
Opening Cash & Cash Equivalents	85.95 Lk	3.97 Cr	26.09 Lk	6.06 Cr
Closing Cash & Cash Equivalent	3.97 Cr	46.08 Lk	6.06 Cr	6.47 Cr

STANDALONE CASH FLOW FOR GUJARAT THEMIS BIOSYN LTD

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	40.88 Cr	59.03 Cr	77.46 Cr	79.33 Cr
Adjustment	-23.99 Lk	15.42 Lk	-2.43 Cr	46.44 Lk
Changes In working Capital	-19.98 Cr	-4.36 Cr	-15.11 Cr	4.19 Cr
Cash Flow after changes in Working Capital	20.66 Cr	54.83 Cr	59.92 Cr	83.99 Cr
Cash Flow from Operating Activities	10.53 Cr	40.31 Cr	39.5 Cr	64.21 Cr
Cash Flow from Investing Activities	-2.25 Cr	-29.83 Cr	-20.41 Cr	-55.21 Cr
Cash Flow from Financing Activitie	-5.16 Cr	-14 Cr	-13.3 Cr	-8.59 Cr
Net Cash Inflow / Outflow	3.12 Cr	-3.51 Cr	5.79 Cr	41.42 Lk
Opening Cash & Cash Equivalents	85.95 Lk	3.97 Cr	26.09 Lk	6.06 Cr
Closing Cash & Cash Equivalent	3.97 Cr	46.08 Lk	6.06 Cr	6.47 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR GUJARAT THEMIS BIOSYN LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	7.26 Cr	7.26 Cr	7.26 Cr	7.26 Cr
Equity - Authorised	13.6 Cr	13.6 Cr	13.6 Cr	25 Cr
Equity - Issued	7.26 Cr	7.26 Cr	7.26 Cr	7.26 Cr
Equity Paid Up	7.26 Cr	7.26 Cr	7.26 Cr	7.26 Cr
Face Value	5	5	5	1
Total Reserves	62.68 Cr	96.06 Cr	141.88 Cr	194.11 Cr
Securities Premium	2.16 Cr	2.16 Cr	2.16 Cr	2.16 Cr
Capital Reserves	15.67 Lk	15.69 Lk	15.69 Lk	15.69 Lk
Profit & Loss Account Balance	60.36 Cr	93.74 Cr	139.56 Cr	191.79 Cr
Reserve excluding Revaluation Reserve	62.68 Cr	96.06 Cr	141.88 Cr	194.11 Cr
Shareholder's Funds	69.95 Cr	103.32 Cr	149.15 Cr	201.38 Cr
Loans - Others	3.03 Cr	0	0	0
Deferred Tax Assets / Liabilities	97.93 Lk	1.02 Cr	1.3 Cr	1.66 Cr
Deferred Tax Assets	32.34 Lk	35.27 Lk	35.02 Lk	38.89 Lk
Deferred Tax Liability	1.3 Cr	1.38 Cr	1.65 Cr	2.05 Cr
Other Long Term Liabilities	1 Cr	41.91 Lk	0	1.22 Cr
Long Term Provisions	51.39 Lk	57.91 Lk	60.39 Lk	68.89 Lk
Total Non-Current Liabilities	2.49 Cr	2.02 Cr	1.9 Cr	3.58 Cr
Trade Payables	3.54 Cr	6.62 Cr	9.54 Cr	9.91 Cr
Sundry Creditors	3.54 Cr	6.62 Cr	9.54 Cr	9.91 Cr
Other Current Liabilities	10.87 Cr	8.6 Cr	4.94 Cr	5.94 Cr
Advances received from customers	21,000	19,000	0	0
Interest Accrued But Not Due	22.99 Lk	0	0	0
Short Term Provisions	11.46 Cr	16.45 Cr	21.22 Cr	20.35 Cr
Provision for Tax	11.26 Cr	16.23 Cr	20.95 Cr	20.04 Cr
Total Current Liabilities	25.87 Cr	31.67 Cr	35.7 Cr	36.2 Cr
Total Liabilities	98.31 Cr	137.02 Cr	186.75 Cr	241.15 Cr
Gross Block	25.52 Cr	28.24 Cr	44.04 Cr	51.21 Cr
Less: Accumulated Depreciation	6.57 Cr	8.81 Cr	11.38 Cr	13.19 Cr
Net Block	18.95 Cr	19.43 Cr	32.66 Cr	38.02 Cr
Capital Work in Progress	2.07 Cr	12.7 Cr	20.59 Cr	91.22 Cr
Long Term Loans & Advances	2.61 Cr	2.77 Cr	10.69 Cr	9.92 Cr
Other Non Current Assets	1.31 Cr	9.21 Cr	41.53 Cr	34.39 Cr
Total Non-Current Assets	24.94 Cr	44.11 Cr	105.48 Cr	173.55 Cr
Inventories	6.05 Cr	11.61 Cr	14.62 Cr	3.33 Cr
Raw Materials	1.16 Cr	1.43 Cr	96.94 Lk	1.06 Cr
Work-in Progress	2.79 Cr	2.62 Cr	3.05 Cr	1.81 Cr
Finished Goods	1.7 Cr	7 Cr	9.8 Cr	2.88 Lk
Packing Materials	1.3 Lk	1.73 Lk	1.48 Lk	1.15 Lk
Stores and Spare	27.44 Lk	33.81 Lk	43.03 Lk	20.69 Lk
Sundry Debtors	14.71 Cr	25.12 Cr	17.91 Cr	27.03 Cr
Debtors more than Six months	0	52.01 Lk	52.01 Lk	52.01 Lk
Debtors Others	15.23 Cr	25.12 Cr	17.91 Cr	27.03 Cr
Cash and Bank	27.64 Cr	12.35 Cr	9.33 Cr	8.16 Cr
Cash in hand	3.93 Lk	90,000	71,000	58,000
Balances at Bank	27.6 Cr	12.34 Cr	9.33 Cr	8.15 Cr
Other Current Assets	1.98 Cr	1.76 Cr	1.37 Cr	92.58 Lk
Interest accrued on Investments	1.69 Cr	1.45 Cr	89.72 Lk	56.67 Lk
Prepaid Expenses	29.45 Lk	31.18 Lk	46.96 Lk	35.91 Lk
Short Term Loans and Advances	22.98 Cr	42.06 Cr	38.04 Cr	28.16 Cr
Advances recoverable in cash or in kind	0	0	12.16 Lk	51.29 Lk
Advance income tax and TDS	10.04 Cr	14.52 Cr	20.42 Cr	20.04 Cr
Inter corporate deposits	0	17.5 Cr	17.5 Cr	0
Total Current Assets	73.37 Cr	92.9 Cr	81.27 Cr	67.6 Cr
Net Current Assets (Including Current Investments)	47.5 Cr	61.23 Cr	45.57 Cr	31.4 Cr
Total Assets	98.31 Cr	137.02 Cr	186.75 Cr	241.15 Cr
Contingent Liabilities	3.88 Cr	4 Cr	4.03 Cr	3.73 Cr
Total Debt	3.03 Cr	0	0	0
Book Value	48.14	0	102.66	0
Adjusted Book Value	48.14	71.11	102.66	27.72

STANDALONE BALANCE SHEET FOR GUJARAT THEMIS BIOSYN LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	7.26 Cr	7.26 Cr	7.26 Cr	7.26 Cr
Equity - Authorised	13.6 Cr	13.6 Cr	13.6 Cr	25 Cr
Equity - Issued	7.26 Cr	7.26 Cr	7.26 Cr	7.26 Cr
Equity Paid Up	7.26 Cr	7.26 Cr	7.26 Cr	7.26 Cr
Face Value	5	5	5	1
Total Reserves	62.68 Cr	96.06 Cr	141.88 Cr	194.11 Cr
Securities Premium	2.16 Cr	2.16 Cr	2.16 Cr	2.16 Cr
Capital Reserves	15.67 Lk	15.69 Lk	15.69 Lk	15.69 Lk
Profit & Loss Account Balance	60.36 Cr	93.74 Cr	139.56 Cr	191.79 Cr
Reserve excluding Revaluation Reserve	62.68 Cr	96.06 Cr	141.88 Cr	194.11 Cr
Shareholder's Funds	69.95 Cr	103.32 Cr	149.15 Cr	201.38 Cr
Loans - Others	3.03 Cr	0	0	0
Deferred Tax Assets / Liabilities	97.93 Lk	1.02 Cr	1.3 Cr	1.66 Cr
Deferred Tax Assets	32.34 Lk	35.27 Lk	35.02 Lk	38.89 Lk
Deferred Tax Liability	1.3 Cr	1.38 Cr	1.65 Cr	2.05 Cr
Other Long Term Liabilities	1 Cr	41.91 Lk	0	1.22 Cr
Long Term Provisions	51.39 Lk	57.91 Lk	60.39 Lk	68.89 Lk
Total Non-Current Liabilities	2.49 Cr	2.02 Cr	1.9 Cr	3.58 Cr
Trade Payables	3.54 Cr	6.62 Cr	9.54 Cr	9.91 Cr
Sundry Creditors	3.54 Cr	6.62 Cr	9.54 Cr	9.91 Cr
Other Current Liabilities	10.87 Cr	8.6 Cr	4.94 Cr	5.94 Cr
Advances received from customers	21,000	19,000	0	0
Interest Accrued But Not Due	22.99 Lk	0	0	0
Short Term Provisions	11.46 Cr	16.45 Cr	21.22 Cr	20.35 Cr
Provision for Tax	11.26 Cr	16.23 Cr	20.95 Cr	20.04 Cr
Total Current Liabilities	25.87 Cr	31.67 Cr	35.7 Cr	36.2 Cr
Total Liabilities	98.31 Cr	137.02 Cr	186.75 Cr	241.15 Cr
Gross Block	25.52 Cr	28.24 Cr	44.04 Cr	51.21 Cr
Less: Accumulated Depreciation	6.57 Cr	8.81 Cr	11.38 Cr	13.19 Cr
Net Block	18.95 Cr	19.43 Cr	32.66 Cr	38.02 Cr
Capital Work in Progress	2.07 Cr	12.7 Cr	20.59 Cr	91.22 Cr
Long Term Loans & Advances	2.61 Cr	2.77 Cr	10.69 Cr	9.92 Cr
Other Non Current Assets	1.31 Cr	9.21 Cr	41.53 Cr	34.39 Cr
Total Non-Current Assets	24.94 Cr	44.11 Cr	105.48 Cr	173.55 Cr
Inventories	6.05 Cr	11.61 Cr	14.62 Cr	3.33 Cr
Raw Materials	1.16 Cr	1.43 Cr	96.94 Lk	1.06 Cr
Work-in Progress	2.79 Cr	2.62 Cr	3.05 Cr	1.81 Cr
Finished Goods	1.7 Cr	7 Cr	9.8 Cr	2.88 Lk
Packing Materials	1.3 Lk	1.73 Lk	1.48 Lk	1.15 Lk
Stores and Spare	27.44 Lk	33.81 Lk	43.03 Lk	20.69 Lk
Sundry Debtors	14.71 Cr	25.12 Cr	17.91 Cr	27.03 Cr
Debtors more than Six months	0	52.01 Lk	52.01 Lk	52.01 Lk
Debtors Others	15.23 Cr	25.12 Cr	17.91 Cr	27.03 Cr
Cash and Bank	27.64 Cr	12.35 Cr	9.33 Cr	8.16 Cr
Cash in hand	3.93 Lk	90,000	71,000	58,000
Balances at Bank	27.6 Cr	12.34 Cr	9.33 Cr	8.15 Cr
Other Current Assets	1.98 Cr	1.76 Cr	1.37 Cr	92.58 Lk
Interest accrued on Investments	1.69 Cr	1.45 Cr	89.72 Lk	56.67 Lk
Prepaid Expenses	29.45 Lk	31.18 Lk	46.96 Lk	35.91 Lk
Short Term Loans and Advances	22.98 Cr	42.06 Cr	38.04 Cr	28.16 Cr
Advances recoverable in cash or in kind	0	0	12.16 Lk	51.29 Lk
Advance income tax and TDS	10.04 Cr	14.52 Cr	20.42 Cr	20.04 Cr
Inter corporate deposits	0	17.5 Cr	17.5 Cr	0
Total Current Assets	73.37 Cr	92.9 Cr	81.27 Cr	67.6 Cr
Net Current Assets (Including Current Investments)	47.5 Cr	61.23 Cr	45.57 Cr	31.4 Cr
Total Assets	98.31 Cr	137.02 Cr	186.75 Cr	241.15 Cr
Contingent Liabilities	3.88 Cr	4 Cr	4.03 Cr	3.73 Cr
Total Debt	3.03 Cr	0	0	0
Book Value	48.14	0	102.66	0
Adjusted Book Value	48.14	71.11	102.66	27.72

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR GUJARAT THEMIS BIOSYN LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	20.77	30.03	39.9	8.14
CEPS(Rs)	21.96	31.56	41.67	8.63
DPS(Rs)	0	11	5.4	1
Book NAV/Share(Rs)	48.14	71.11	102.66	27.72
Tax Rate(%)	26.18	26.1	25.17	25.43
Margin Ratios
Core EBITDA Margin(%)	44.53	50.54	49.82	46.36
EBIT Margin(%)	46.23	52.12	52.13	46.85
Pre Tax Margin(%)	45.14	51.4	52	46.72
PAT Margin (%)	33.32	37.98	38.91	34.84
Cash Profit Margin (%)	35.24	39.93	40.64	36.92
Performance Ratios
ROA(%)	35.65	37.08	35.81	27.65
ROE(%)	53.82	50.35	45.92	33.76
ROCE(%)	67.89	67.91	61.53	45.4
Asset Turnover(x)	1.07	0.98	0.92	0.79
Sales/Fixed Asset(x)	3.82	4.27	4.12	3.57
Working Capital/Sales(x)	1.91	1.88	3.27	5.41
Efficiency Ratios
Fixed Capital/Sales(x)	0.26	0.23	0.24	0.28
Receivable days	70.42	63.29	52.71	48.29
Inventory Days	24.34	28.06	32.13	19.29
Payable days	40.68	115.11	114.42	99.37
Valuation Parameters
PER(x)	9.8	13.57	17.2	48.64
PCE(x)	9.27	12.91	16.47	45.89
Price/Book(x)	4.23	5.73	6.69	14.29
Yield(%)	0	2.7	0.79	0.25
EV/Net Sales(x)	3	5.05	6.63	16.9
EV/Core EBITDA(x)	6.22	9.33	12.31	34.53
EV/EBIT(x)	6.48	9.68	12.72	36.06
EV/CE(x)	2.76	4.23	5.29	14.25
M Cap / Sales	3.27	5.15	6.69	16.94
Growth Ratio
Net Sales Growth(%)	6.39	26.82	29.71	14.45
Core EBITDA Growth(%)	29.97	42.43	29.22	3.59
EBIT Growth(%)	30.09	42.99	29.74	2.48
PAT Growth(%)	27.48	44.55	32.88	2.06
EPS Growth(%)	27.47	44.55	32.88	-79.59
Financial Stability Ratios
Total Debt/Equity(x)	0.04	0	0	0
Current Ratio(x)	2.84	2.93	2.28	1.87
Quick Ratio(x)	2.6	2.57	1.87	1.78
Interest Cover(x)	42.66	72.31	386.97	347.14
Total Debt/Mcap(x)	0.01	0	0	0

FINANCIAL RATIOS (STANDALONE) FOR GUJARAT THEMIS BIOSYN LTD

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	20.77	30.03	39.9	8.14
CEPS(Rs)	21.96	31.56	41.67	8.63
DPS(Rs)	0	11	5.4	1
Book NAV/Share(Rs)	48.14	71.11	102.66	27.72
Tax Rate(%)	26.18	26.1	25.17	25.43
Margin Ratios
Core EBITDA Margin(%)	44.53	50.54	49.82	46.36
EBIT Margin(%)	46.23	52.12	52.13	46.85
Pre Tax Margin(%)	45.14	51.4	52	46.72
PAT Margin (%)	33.32	37.98	38.91	34.84
Cash Profit Margin (%)	35.24	39.93	40.64	36.92
Performance Ratios
ROA(%)	35.65	37.08	35.81	27.65
ROE(%)	53.82	50.35	45.92	33.76
ROCE(%)	67.89	67.91	61.53	45.4
Asset Turnover(x)	1.07	0.98	0.92	0.79
Sales/Fixed Asset(x)	3.82	4.27	4.12	3.57
Working Capital/Sales(x)	1.91	1.88	3.27	5.41
Efficiency Ratios
Fixed Capital/Sales(x)	0.26	0.23	0.24	0.28
Receivable days	70.42	63.29	52.71	48.29
Inventory Days	24.34	28.06	32.13	19.29
Payable days	40.68	115.11	114.42	99.37
Valuation Parameters
PER(x)	9.8	13.57	17.2	48.64
PCE(x)	9.27	12.91	16.47	45.89
Price/Book(x)	4.23	5.73	6.69	14.29
Yield(%)	0	2.7	0.79	0.25
EV/Net Sales(x)	3	5.05	6.63	16.9
EV/Core EBITDA(x)	6.22	9.33	12.31	34.53
EV/EBIT(x)	6.48	9.68	12.72	36.06
EV/CE(x)	2.76	4.23	5.29	14.25
M Cap / Sales	3.27	5.15	6.69	16.94
Growth Ratio
Net Sales Growth(%)	6.39	26.82	29.71	14.45
Core EBITDA Growth(%)	29.97	42.43	29.22	3.59
EBIT Growth(%)	30.09	42.99	29.74	2.48
PAT Growth(%)	27.48	44.55	32.88	2.06
EPS Growth(%)	27.47	44.55	32.88	-79.59
Financial Stability Ratios
Total Debt/Equity(x)	0.04	0	0	0
Current Ratio(x)	2.84	2.93	2.28	1.87
Quick Ratio(x)	2.6	2.57	1.87	1.78
Interest Cover(x)	42.66	72.31	386.97	347.14
Total Debt/Mcap(x)	0.01	0	0	0

SHARE HOLDING PATTERN FOR GUJARAT THEMIS BIOSYN LTD

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	74.99	74.99	74.99	74.99	74.99	74.99	70.86	70.86	70.86	70.86
FII %	0.00	0.00	0.01	0.01	0.01	0.01	0.86	1.05	1.44	1.49
DII %	0.28	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00
Public %	24.69	24.97	24.96	24.96	24.96	24.96	28.23	27.26	26.51	26.47

PEER COMPARISON FOR GUJARAT THEMIS BIOSYN LTD

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR GUJARAT THEMIS

Exchange Date	Purpose	Book Closure Dates
BSE 21-Oct-2024	Board Meeting - Quarterly Results	25-Oct-2024
BSE 16-Jul-2024	Board Meeting - Quarterly Results	26-Jul-2024
BSE 14-May-2024	Bonus issue - Bonus issue Inter alia, Recommended dividend for Financial Year ended 31 st March, 2024 Rs. 0.25/ ? i.e.@ 25% per- equity share having face value of Re.1 /? aggregating to Rs. 1,81 ,60,877.50/ ?. The payment is subject to the appro?val of shareholders at the ensuing Annual General Meeting. 2. Issue of 1 (One) Bonus Shares for every 2 (Two) Equity Shares held by the Equity Shareholders of the Compa...	14-May-2024
BSE 14-May-2024	Book Closure - Rs.0.2500 per share(25%)Final Dividend & A.G.M.	16-Jul-2024 23-Jul-2024
BSE 14-May-2024	AGM - Rs.0.2500 per share(25%)Final Dividend & A.G.M.	23-Jul-2024 23-Jul-2024
BSE 14-May-2024	Dividend - Rs.0.2500 per share(25%)Final Dividend
BSE 03-May-2024	Board Meeting - Final Dividend & Audited Results & Bonus issue	14-May-2024
BSE 03-May-2024	Bonus issue - Final Dividend & Audited Results & Bonus issue	14-May-2024
BSE 22-Feb-2024	Dividend - Rs.0.7500 per share(75%)Interim Dividend
BSE 29-Jan-2024	Board Meeting - Quarterly Results	10-Feb-2024
BSE 25-Oct-2023	Board Meeting - Quarterly Results	04-Nov-2023
BSE 03-Aug-2023	Board Meeting - Quarterly Results	10-Aug-2023
BSE 02-Aug-2023	Board Meeting - Quarterly Results	12-Aug-2023
BSE 15-May-2023	Book Closure - Rs.1.0000 per share(20%)Final Dividend & A.G.M.	02-Sep-2023 09-Sep-2023
BSE 15-May-2023	AGM - Rs.1.0000 per share(20%)Final Dividend & A.G.M.	09-Sep-2023 09-Sep-2023
BSE 15-May-2023	Split or Consolidation - Inter alia, approved:- 1. Appointed CS Ketan R. Shirwadkar (ACS 37829) or failing him, CS Prakash Nagringrekar (ACS 5941), Designated Partners of HSPN & Associates LLP, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting EVoting and Polling at the 4274 Annual General Meeting. 2. Recommended dividend for Financial Year ended 31.03.2023 of Rs.1/- l.e. @ 20% per equity share havi...
BSE 15-May-2023	Dividend - Rs.1.0000 per share(20%)Final Dividend
BSE 04-May-2023	Board Meeting - Audited Results & Stock Split & Final Dividend	13-May-2023
BSE 04-May-2023	Split or Consolidation - Audited Results & Stock Split & Final Dividend
BSE 27-Jan-2023	Board Meeting - Quarterly Results	03-Feb-2023
BSE 01-Dec-2022	Dividend - Rs.4.4000 per share(88%)Interim Dividend
BSE 16-Nov-2022	Board Meeting - Interim Dividend	21-Nov-2022
BSE 28-Oct-2022	Board Meeting - Quarterly Results	07-Nov-2022
BSE 27-Jul-2022	Book Closure - Rs.4.0000 per share(80%)Final Dividend & A.G.M.	31-Aug-2022 07-Sep-2022
BSE 27-Jul-2022	AGM - Rs.4.0000 per share(80%)Final Dividend & A.G.M.	07-Sep-2022 07-Sep-2022
BSE 19-Jul-2022	Board Meeting - Quarterly Results	27-Jul-2022
BSE 20-May-2022	Dividend - Rs.4.0000 per share(80%)Final Dividend
BSE 12-May-2022	Board Meeting - Final Dividend & Audited Results	20-May-2022
BSE 31-Jan-2022	Board Meeting - Quarterly Results	11-Feb-2022
BSE 11-Nov-2021	Dividend - Rs.7.0000 per share(140%)Interim Dividend

CORPORATE ANNOUNCEMENTS FOR GUJARAT THEMIS

Exchange Date	Category File	Description
BSE 29-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer to the attachment.
BSE 28-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Please refer to the attachment.
BSE 25-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Please refer to the attachment.
BSE 25-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Please refer to the attachment.
BSE 25-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Retirement Please refer to the attachment.
BSE 25-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Director Please refer to the attachment.
BSE 25-Oct-2024	Outcome FILE	Results: Financial Results For The Quarter And Half Year Ended 30Th September 2024 Please refer to the attachment.
BSE 25-Oct-2024	Outcome FILE	Board Meeting Outcome for Un-Audited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2024 Please refer to the attachment.
BSE 19-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer to the attachement.
BSE 18-Oct-2024	Intimation FILE	Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2024 GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Please refer to our intimation of Board Meeting scheduled on 25th October 2024.
BSE 15-Oct-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer"s Report Please refer to the attachment for your information please.
BSE 15-Oct-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot Please refer to the attachment for your information.
BSE 09-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Please refer to the RTA certificate under Reg 74 (5) of SEBI (DP) Reg 2018
BSE 01-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer to the attachment.
BSE 26-Sep-2024	Intimation FILE	Closure of Trading Window Please refer to our intimation of closure of Trading Window for the declaration of un-audited financial results for the quarter and half year ending 30th September 2024
BSE 14-Sep-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Please refer to the attachment for the publication of notice of Postal Ballot in the newspapers dated 14.09.2024
BSE 13-Sep-2024	Intimation FILE	Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Please refer to the attachment.
BSE 03-Sep-2024	General Announcements FILE	Appointment of Company Secretary and Compliance Officer Please refer to the attachment.
BSE 30-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer to the attachment.
BSE 29-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer to the attachment.
BSE 28-Aug-2024	General Announcements FILE	Announcement Under Regulation 30 - Updates Please refer to the attachment.
BSE 14-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer attachment
BSE 14-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Allotment The Board of Directors of the Company through Circular resolution passed today have allotted 36321755 nos. of equity shares of Rs. 1/- each in the ratio of 1:2
BSE 02-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Please refer to the attachment
BSE 01-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please refer the attachment.
BSE 29-Jul-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publication of Un-audited Financial Results for the quarter ended 30th June 2024.
BSE 27-Jul-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation As per the attached file.
BSE 26-Jul-2024	Intimation FILE	Corporate Action - Record Date Fixed For Issue Of Bonus Shares As per the attachment
BSE 26-Jul-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Appointment of Mr. K.G. Ananthakrishnan as an Additional Director in the category of Non-Executive Independent Director .
BSE 26-Jul-2024	Outcome FILE	Results - Financial Results For The Quarter Ended 30Th June 2024. Please refer to the attachment.

INSIDER TRADING FOR GUJARAT THEMIS

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 15-Dec-2021 15-Dec-2021	Sell Market	3,704 @ 0.00 (0.02 %)	Avantika Vijay Agarwal
BSE 14-Dec-2021 14-Dec-2021	Sell Market	656 @ 0.00 (0.01 %)	Ms Avantika Vijay Agarwal
BSE 13-Dec-2021 13-Dec-2021	Sell Market	9,032 @ 0.00 (0.06 %)	Ms Avantika Vijay Agarwal
BSE 17-Sep-2021 17-Sep-2021	Buy Inter-se Transfer	3,850,000 @ 0.00 (26.50 %)	Pharmaceutical Business Group India Ltd
BSE 17-Sep-2021 17-Sep-2021	Sell Inter-se Transfer	3,850,000 @ 0.00 (0.00 %)	Yuhan Corporation

BULK BLOCK DEALS FOR GUJARAT THEMIS BIOSYN LTD

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 27-Dec-2023	Buy BULK	490,000 @ 215.00	MC JAIN INFOSERVICES PRIVATE LIMITED
BSE 27-Dec-2023	Sell BULK	3,000,000 @ 215.35	PHARMACEUTICAL BUSINESS GROUP I LTD

DIVIDEND BY GUJARAT THEMIS BIOSYN LTD

Ex Dividend Date	Dividend Type	Dividend
15-Jul-2024	DIVIDEND	0.25
22-Feb-2024	INTERIM DIVIDEND	0.75
01-Sep-2023	DIVIDEND	1
02-Dec-2022	INTERIM DIVIDEND	4.4
29-Aug-2022	DIVIDEND	4
24-Nov-2021	INTERIM DIVIDEND	2
24-Nov-2021	SPECIAL DIVIDEND	5